The effect of sensory nerve stimulation on sensory nerve function in people with peripheral neuropathy associated with diabetes

Neurological Research

Volumn 29, Issue 7, 2007, Pages 743-748

  Khalil, Zeinab ^a,b   Ogrin, Rajna ^c   Darzins, Peteris J ^d  

^a UNIVERSITY OF SHARJAH   (United Arab Emirates)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HEIDELBERG REPATRIATION HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Diabetes; Neurogenic inflammation; Peripheral neuropathy; Sensory nerve stimulation; Treatment

Indexed keywords

CAPSAICIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE FUNCTION; NERVE STIMULATION; OXYGEN TENSION; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; SENSORY NERVE;

AGED; CAPILLARIES; CAPSAICIN; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NEUROGENIC INFLAMMATION; NEURONS, AFFERENT; OXYGEN CONSUMPTION; PAIN MEASUREMENT; PAIN THRESHOLD; PERIPHERAL NERVES; PLACEBOS; SENSATION DISORDERS; SENSORY THRESHOLDS; SKIN; TREATMENT OUTCOME;

EID: 36048934374     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X208095     Document Type: Article

References (46)

1. Johnson PC, Doll SC, Cromey DW. Pathogenesis of diabetic neuropathy. Ann Neurol 1986; 19: 450-457
2. Valensi P, Giroux C, Seeboth-Ghalayini B, et al. Diabetic peripheral neuropathy: Effects of age, duration of diabetes, glycemic control, and vascular factors. J Diabetes Complications 1997; 11: 27-34
3. O'Brien IA, Corrall RJ. Epidemiology of diabetes and its complications. N Engl J Med 1988; 318: 1619-1620
4. Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In: Dyck P, Thomas P, eds. Peripheral Neuropathy, Philadelphia, PA: WB Saunders, 1993: pp. 1219-1250
5. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: Basis for prevention. Diabetes Care 1990; 13: 513-521
6. Edmonds ME, Blundell MP, Morris ME, et al. Improved survival of the diabetic foot: The role of a specialized foot clinic. Q J Med 1986; 60: 763-771
7. Larsen K, Holstein P, Deckert T. Limb salvage in diabetics with foot ulcers. Prosthet Orthot Int 1989; 13: 100-103
8. Boyko EJ, Ahroni JH, Smith DG, et al. Increased mortality associated with diabetic foot ulcer. Diabet Med 1996; 13: 967-972
9. Khalil Z, Helme R. Sensory peptides as neuromodulators of wound healing in aged rats. J Gerontol A Biol Sci Med 1996; 51: B354-B361
10. Maggi C. The pharmacology of the efferent function of sensory nerves. J Auton Pharmacol 1991; 11: 173-208
11. Anand P, Ghatei M, Christofides N, et al. Differential neuropeptide expression after visceral and somatic nerve injury in the cat and rat. Neurosci Lett 1991; 128: 57-60
12. Chiang HY, Huang IT, Chen WP, et al. Regional difference in epidermal thinning after skin denervation. Exp Neurol 1998; 154: 137-145
13. Parkhouse N, Le Quesne PM. Qualitative objective assessment of peripheral nociceptive C-fibre function. J Neurol Neurosurg Psychiatry 1988; 51: 28-34
14. Walmsley D, Wiles PG. Early loss of neurogenic inflammation in the human diabetic foot. Clin Sci (Lond) 1991; 80: 605-610
15. Forst T, Pfutzner A, Bauersachs R, et al. Comparison of the microvascular response to transcutaneous electrical nerve stimulation and postocclusive ischemia in the diabetic foot. J Diabetes Complications 1997; 11: 291-297
16. Levy DM, Karanth SS, Springall DR, et al. Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: An immunocytochemical study. Diabetologia 1989; 32: 427-433
17. Forst T, Pfutzner A, Kunt T, et al. Skin microcirculation in patients with Type 1 diabetes with and without neuropathy after neurovascular stimulation. Clin Sci (Lond) 1998; 94: 255-261
18. Humphrey AR, Dowse GK, Thoma K, et al. Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention - a 12-year follow-up study in Nauru. Diabetes Care 1996; 19: 710-714
19. Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med 1988; 318: 1306-1309
20. Ardron ME, Helme RD, McKernan S. Microvascular skin responses in elderly people with varicose leg ulcers. Age Ageing 1991; 20: 124-128
21. Ogrin R, Darzins P, Khalil Z. Age-related changes in microvascular blood flow and transcutaneous oxygen tension under basal and stimulated conditions. J Gerontol A Biol Sci Med Sci 2005; 60: 200-206
22. Dyck PJ, Karnes JL, O'Brien P, et al. The spatial distribution of fibre loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986; 19: 440-449
23. Dyck PJ, Lais A, Karnes JL, et al. Fibre loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986; 19: 425-439
24. Kilo S, Berghoff M, Hilz M, et al. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology 2000; 54: 1246-1252
25. Fried K, Brodin E, Theodorsson E. Substance P-, CGRP- and NPY-immunoreactive nerve fibers in rat sciatic nerve-end neuromas. Regul Pept 1989; 25: 11-24
26. Zochodne DW, Ho LT. Influence of perivascular peptides on endoneurial blood flow and microvascular resistance in the sciatic nerve of the rat. J Physiol 1991; 444: 615-630
27. Khalil Z, Merhi M. Effects of aging on neurogenic vasodilator responses evoked by transcutaneous electrical nerve stimulation: Relevance to wound healing. J Gerontol A Biol Sci Med Sci 2000; 55: B257-B263
28. Khalil Z, LeVasseur S, Merhi M, et al. Sympathetic modulation of sensory nerve activity with age: Human and rodent skin models. Clin Exp Pharmacol Physiol 1997; 24: 883-886
29. McGill M, Molyneaux L, Spencer R, et al. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care 1999; 22: 598-602
30. Liniger C, Albeanu A, Bloise D, et al. The tuning fork revisited. Diabet Med 1990; 7: 859-864
31. Pitei DL, Watkins PJ, Stevens MJ, et al. The value of the Neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabet Med 1994; 11: 872-876
32. Masson EA, Veves A, Fernando D, et al. Current perception thresholds: A new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989; 32: 724-728
33. Dyck P, Karnes J, O'Brien P, et al. Detection thresholds of cutaneous sensation in humans. In: Dyck P, Thoma P, Lambert E, Bunge R, eds. Peripheral Neuropathy, Philadelphia, PA: WB Saunders, 1978: pp. 1103-1038
34. Khalil Z, Ralevic V, Bassirat M, et al. Effect of ageing on sensory nerve function in rat skin. Brain Res 1994; 641: 265-272
35. Obeid AN, Barnett NJ, Dougherty G, et al. A critical review of laser Doppler flowmetry. J Med Eng Technol 1990; 14: 178-181
36. 2, 1st edn, New York: Thieme-Stratton Inc., 1981
37. Rodriguez-Pena A, Botana M, Gonzalez M, et al. Expression of neurotrophins and their receptors in sciatic nerve of experimentally diabetic rats. Neurosci Lett 1995; 200: 37-40
38. Kim J, Kyriazi H, Greene DA. Normalization of Na(+)-K( +)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro. Diabetes 1991; 40: 558-567
39. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995; 38: 1425-1433
40. Kochman AB, Carnegie DH, Burke TJ. Symptomatic reversal of peripheral neuropathy in patients with diabetes. J Am Podiatr Medl Assoc 2002; 92: 125-130
41. Troni W, Carta Q, Cantello R, et al. Peripheral nerve function and metabolic control in diabetes mellitus. Ann Neurol 1984; 16: 178-183
42. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
43. Stansberry K, Hill M, Shapiro S, et al. Impairment of peripheral blood flow responses in diabetes resembles an enhanced aging effect. Diabetes Care 1997; 20: 1711-1716
44. Merhi M, Helme RD, Khalil Z. Age-related changes in sympathetic modulation of sensory nerve activity in rat skin. Inflamm Res 1998; 47: 239-244
45. Peters EJ, Armstrong DG, Wunderlich RP, et al. The benefit of electrical stimulation to enhance perfusion in persons with diabetes mellitus. J Foot Ankle Surg 1998; 37: 396-400
46. Kaada B. Vasodilation induced by transcutaneous nerve stimulation in peripheral ischemia (Raynaud's phenomenon and diabetic polyneuropathy). Eur Heart J 1982; 3: 303-314